IRAK1BP1 and neoplasm: In the context of cancer, chronic inflammation is often associated with tumor development (18); therefore it would be interesting to test if the reduced expression of IRAK1BP1 in tumor cells leads to elevated inflammatory signals and contributes to cancer progression.